NasdaqGS:IRTCMedical Equipment
The Bull Case for iRhythm Technologies (IRTC) Could Change Following Landmark Real-World Study of Zio LTCM
iRhythm Technologies announced that a large real-world study published in the American Journal of Managed Care found its Zio® long-term continuous monitoring (LTCM) service outperformed other ambulatory cardiac monitoring methods in clinical outcomes, diagnostic speed, and healthcare cost reduction for commercially insured adults in the U.S.
This publication expands on prior findings in Medicare patients and highlights the value of Zio LTCM with the highest rate of new arrhythmia diagnoses,...